Skip Navigation


Annals of Oncology Advance Access originally published online on April 20, 2006
Annals of Oncology 2006 17(9):1465-1466; doi:10.1093/annonc/mdl051
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/9/1465-a    most recent
mdl051v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Scherwath, A
Right arrow Search for Related Content
PubMed
Right arrow Articles by Scherwath, A
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 European Society for Medical Oncology

letters to the editor

Reply to ‘Promotion of neurogenesis by human stem cells in high-risk breast cancer survivals after stem-cell supported high-dose therapy’ by K. Altundag et al. (Ann Oncol 2006; 17: 1465)

A Scherwath

Institute of Medical Psychology, Hamburg-Eppendorf University Medical Center, Martinistrasse 52, 20246 Hamburg, Germany

(E-mail: a.scherwath@uke.uni-hamburg.de)

The first 10% of the full text of this article appears below.

Altundag et al. [1] provide an interesting interpretation of our findings on neuropsychological function in high-risk breast cancer survivors after different treatment regimens [2]. The authors propose that the slightly better global cognitive outcome in breast cancer patients . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?